Delicaflavone Reverses Cisplatin Resistance via Endoplasmic Reticulum Stress Signaling Pathway in Non-Small Cell Lung Cancer Cells

BACKGROUND: The incidence and mortality of lung cancer continue to increase around the world; in 2018, new lung cancer cases accounted for 11.6% of all cancer cases, and lung cancer deaths accounted for 18.4% of cancer deaths. Cisplatin (DDP) is a first-line chemotherapy drug for lung cancer; howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xuewen, Chen, Bing, Xu, Danfen, Li, Zhijun, Sui, Yuxia, Lin, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568618/
https://www.ncbi.nlm.nih.gov/pubmed/33116611
http://dx.doi.org/10.2147/OTT.S255586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568618/
https://www.ncbi.nlm.nih.gov/pubmed/33116611
http://dx.doi.org/10.2147/OTT.S255586

Ejemplares similares